ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

ピナゼパム

Pinazepam

HCID 40391
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
52463-83-9
標準SMILES
C#CCN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21
InChIKey
MFZOSKPPVCIFMT-UHFFFAOYSA-N
分子式
C18H13ClN2O
平均分子量
308.8 g/mol
単同位体質量
308.0716407

概要

Pinazepam is a benzodiazepine.

名称と識別子

優先名称
Pinazepam
IUPAC
7-chloro-5-phenyl-1-prop-2-ynyl-3H-1,4-benzodiazepin-2-one
現地名
ピナゼパム
英語名
pinazepam
分子式
C18H13ClN2O
分子量
308.76

名称と別名

PinazepamDomar52463-83-9Pinazepamum7-Chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-benzodiazepin-2-one7-Chloro-1-propargyl-5-phenyl-2H-1,4-benzodiazepin-2-one5286RBZ882DTXSID30234757-chloro-5-phenyl-1-(prop-2-yn-1-yl)-2,3-dihydro-1H-1,4-benzodiazepin-2-onepropazepamRefChem:929293DTXCID203475
名称をさらに表示
ドマルピナゼパム7-クロロ-1,3-ジヒドロ-5-フェニル-1-(2-プロピニル)-2H-1,4-ベンゾジアゼピン-2-オン7-クロロ-5-フェニル-1-(プロパ-2-イン-1-イル)-2,3-ジヒドロ-1H-1,4-ベンゾジアゼピン-2-オンZami-905pinazepam USP/EP/BP7-chloro-5-phenyl-1-prop-2-ynyl-3H-1,4-benzodiazepin-2-one2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl-1-(2-propyn-1-yl)-
N05BA147-chloro-5-phenyl-1-propargyl-1,4-benzodiazepin-2-one257-934-9Pinazepam [INN]ZAMI 905DunaZ-9052H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-

データベース識別子

CAS
52463-83-9

物性

構造計算による物性

XLogP
3.1
極性表面積
32.7 Ų
水素結合供与体数
0
水素結合受容体数
2
回転可能結合数
2
重原子数
22
形式電荷
0
複雑度
500

実験および物理化学的性質

Drugs · 3 件

DEA NFLIS-Drug Category -> Benzodiazepines

DEA Schedule IV Controlled Substance -> Depressants

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

LogP2.87
Melting Point141 °C
Physical DescriptionSolid

物理化学的性質

融点
140 · 140-142°
沸点
523.6 · 523.6±50.0 °C(Predicted)
比重(密度)
1.2151 · 1.2151 (rough estimate)
屈折率
1.58 · 1.5800 (estimate)
溶解性
DMSO (Slightly), Methanol (Slightly)
外見
Solid
酸解離定数(Pka)
2.34 · pKa 2.34 (Uncertain)
色
Off-White to Pale Beige
安定性
Light Sensitive

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

Regulatory InformationDEA schedule IV controlled substance

毒性情報

Treatment · 1 件

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

Toxicity Summary · 1 件

Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

化学と産業

薬理情報

ATC Code · 2 件

N - Nervous system

QN - Nervous system

MeSH Pharmacological Classification · 1 件

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Cellular LocationsMembrane

応用分野

使用Pinazepam is a is a benzodiazepine. Pinazepam possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Pinazepam is less toxic than Diazepam. This is a contolled substance (depressant). Anxiolytic.

上流・下流製品情報

上流原料

Phthalimido Acetyl Chlorideヒドラジン一水和物プロパルギルブロミド2-アミノ-5-クロロベンゾフェノンノルダゼパム

関連反応

2 件
反応記録を作成
HRID 1446802 の反応式
HRID 1446802生成物としてuspto-grants-1982_02
HRID 1446803 の反応式
HRID 1446803生成物としてuspto-grants-1982_02

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
PubChem CID
40391
DTXSID
DTXSID3023475
ChEMBL
CHEMBL1213352
ChEBI
CHEBI:135315
UNII
5286RBZ882
EC Number
257-934-9
Nikkaji
J9.933C

安全データ

ridadr
3249
毒性
LD50 in mice, rats (mg/kg): 1355, 5819 orally; 266, 622 i.p. (Scrollini, 1975); Also reported as LD50 in mice (mg/kg): 670 orally (Podesva, Vagi)
hazard_class
6.1(b)
packing_group
III
DEA Controlled Substances
CSCN: 2883CSA SCH: Schedule IVNARC: No